Medicine Man Technologies, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Medicine Man Technologies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q4 2023.
  • Medicine Man Technologies, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was -$8.63M, a 59.3% increase year-over-year.
  • Medicine Man Technologies, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was -$18.1M, a 10.2% decline year-over-year.
  • Medicine Man Technologies, Inc. annual Nonoperating Income (Expense) for 2023 was -$18.1M, a 10.2% decline from 2022.
  • Medicine Man Technologies, Inc. annual Nonoperating Income (Expense) for 2022 was -$16.4M, a 293% decline from 2021.
  • Medicine Man Technologies, Inc. annual Nonoperating Income (Expense) for 2021 was $8.51M, a 229% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$18.1M -$8.63M +$12.6M +59.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$30.7M -$3.8M -$92.1K -2.48% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$30.6M -$6.42M -$35.6M -122% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.06M $758K +$21.5M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$16.4M -$21.2M -$32.8M -283% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $16.4M -$3.71M -$2.16M -139% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $18.5M $29.2M +$29.1M +18435% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$10.5M -$20.7M -$19M -1114% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.51M $11.6M +$12.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$3.71M -$1.56M -$2.26M -321% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.45M $158K +$403K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$1.85M -$1.71M -$4.44M -163% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-05-27
Q4 2020 $2.59M -$604K -$2.19M -138% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $4.78M $705K +$1.61M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $3.17M -$246K +$234K +48.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $2.94M $2.73M +$3.42M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$477K $1.59M +$4.84M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$5.32M -$902K -$3.48M -135% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.84M -$480K -$508K -1782% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$1.33M -$684K -$691K -9344% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$638K -$3.25M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $2.58M +$2.75M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $28.5K -$39.6K -58.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $7.4K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q3 2017 -$166K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $68.1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.